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The emergence of drug resistant bacteria has now
become a major public health problem worldwide
(Cohen, 2000; Kumarasamy et al., 2010; Sengupta
et al., 2013). WHO report (2017) on global
surveillance of antimicrobial resistance revealed a
widespread development of resistance in both gram
positive and gram negative bacteria which had
threatened millions of people worldwide. A rapid
increase in the number of drug-resistant bacteria
and the incidence nosocomial infections pose a
challenge to conventional therapies using existing
antibiotics, leading to the need in finding
alternative microbicides to control these infections
(Lakshmaiah et al., 2015). Thus, a discovery of new
and effective treatments that can replace current
available antibiotics has become a critical area of
research globally.
Anurans inhabit a wide variety of habitat types
from barren deserts to deep freshwater lakes and
may spend most of their life underground or high
in the cloud of a forest canopy. They are vulnerable
towards injuries, predators, parasitisation, micro-
organism’s infections and wounds (Clarke, 1997).
The frog skin plays key roles in the everyday
survival of the amphibians and contributes to their
ability to exploit a wide range of habitats and
ecological conditions. Upon stress or injuries, frogs
secrete secretion from the glandular gland as their
first line host defense system against penetrating
infectious microorganisms (Schadich, 2009,
Hancock and Diamond, 2000). Glandular gland also
serves as a toxic gland containing antimicrobial
peptides (AMPs) and can be found concentrated at
the head and neck of the frogs (Rollin-Smith et al.,
2002). Most AMPs are cationic in nature and share
a net positive charge at neutral pH with the high
content of hydrophobic residues and an amphipathic
character (Galdiero et al., 2013; Power & Hancock,
2003). These characteristics allow the frog skin
peptides to kill bacteria through cell lysis by
binding to negatively charged components of the
bacterial membrane (Schadich et al., 2013). The
AMPs attract attention due to their effectiveness in
killing both gram-negative and gram-positive
bacteria, without any of the undesirable effects of
antibiotic resistance (Conlon and Sonnevand, 2011;
Galdiero et al., 2015; Schadich, 2009). Thus,
amphibian’s skin secretions have become the target
for the screening and subsequent development of
AMPs.
Bornean frogs are the endogenous frogs that
inhabit Borneo, an island divided between
Indonesia, Brunei and East Malaysia (Sabah and
Sarawak).  Approximately, more than 150 species of
frogs occur in Borneo (Inger and Stuebing, 2005)
and are widely distributed throughout the island.
Their habitats range from peat swamps, terrane,
waterfalls, streams, high altitudes to the forest
floors of the tropical rainforest. There are seven
families of Bornean frogs present in the island which
are Bombinatoridae, Bufonidae, Ceralobatrachidae,
Dicroglossidae, Microhylidae, Ranidae and
Rhacophoridae.
The current study focuses on the individuals
belonging to the family of Ranidae, which is often
referred to as ‘true frog’ under the suborder
Neobatrachia.  It has been documented that the
skin secretions from frogs in the Ranidae family
contained brevinin, esulentin and ranateurin that are
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able to inhibit the growth of various bacteria strains
(Conlon et al., 2011; Kumar et al., 2015; Wang et
al., 2012(a); Wang et al., 2012 (b)). A study on a
species of Bornean frog from the family of Ranidae
(Conlon et al., 2008) revealed that the skin
secretions of Hylarana picturata contained AMPs
belonging to the brevinin-1, brevinin-2 and
temporin families. The study also revealed that skin
secretion of frogs from another Ranidae family,
Odorrana hosii contained brevinin-1, brevinin-2,
esculentin-1, esculentin-2 and nigrocin-2 (Conlon
et al., 2008). Apart from the works done by Conlon
and coworkers, research on the AMPs from the skin
secretions of Bornean frogs remain scarce, thus
warrants increased efforts to sample these peptides
and to study their potential against bacterial species
associated with nosocomial infections.
In this study, the presence of AMPs in the skin
secretion of several species in the Ranidae family
was investigated and partially purified and
characterized. Our study focused on activities of
skin antimicrobial peptides of Bornean Ranidae
frogs against two pathogens associated with
nosocomial infections, Staphylococcus aureus
(ATCC 25923) and Escherichia coli (ATCC 25922)
and yeast Candida albicans. Natural peptide
mixture of skin peptides of six different Ranidae
frog species including: Pulchrana glandulosa,
Pulchrana signata, Pulchrana baramica,
Chalcorana raniceps, Odorrana hosii and
Meristogenys jerboa were collected and assayed for
microbial growth inhibition. Adult Bornean frogs of
the selected species of both sexes (n=5 specimens
per species) were collected at few sites in Miri and
Kuching. The captured frogs were placed in a glass
beaker and anaesthetized using absorbent cotton
immersed in 1 ml anhydrous diethyl ether for 10
mins (Lai et al., 2010). The skin secretions from the
dorsal part of the frogs were then washed with sterile
water containing 1 mM EDTA. The secretions
collected were immediately centrifuged at 3220
rev/min for 30 min at 4°C and freeze dried.
Concentration and partial purifications of crude
extracts were conducted using Sep Pak C-18 (Minn
et al., 1998). Sep Pak cartridge was first activated
with 12 ml of acetonitrile (2ml per cartridge),
followed by 0.1% of trifluoroacetic acid in 99.9%
water. After being loaded with 5 ml of the
supernatant at a flow rate of 4ml/min, the cartridge
was washed with 0.1% trifluoroacetic acid in
99.9% water and the bound peptide were eluted
with 12 ml of 70% acetonitrile containing 0.1%
trifluoroacetic acid (2 ml per cartridge). The final
elution was collected in a glass beaker and aliquoted
into 1.5 ml microcentrifuge tubes. Samples were
stored at -80°C freezer.
Then, 20µg/µl of peptide samples were separated
on a 30% polyacrylamide gel at 200V for 60 min
(Schägger, 2006). The gel was subsequently fixed
using 5% glutaraldehyde solution for 2 hours and
protein bands were stained using the silver staining
(Gromova and Celis, 2006).
The partially purified peptides were initially
screened for antimicrobial activity by disk diffusion
assay. Initial dose screening assay showed no
inhibition zone at the peptide concentration of lower
than 250 µg/ml. Therefore, based on this finding,
500 and 250 µg/ml of peptides were impregnated
into sterile disk and placed onto Mueller Hinton agar
inoculated with 106 CFU/ml of reference strains of
Staphylococcus aureus (ATCC 25923), Escherichia
coli (ATCC 25922) and Candida albicans for 18
hours at 37°C. After an overnight incubation, the
diameter of the inhibition zone was measured.
Further antimicrobial testing was performed
by determining the Minimum Inhibitory Concen-
trations (MIC) of the partially purified peptides from
the frog skin secretions according to previously
published assay (Schadich, 2009, Schadich 2013).
Serial dilutions of the peptides (500, 250, 125, 62.5,
31.2, 15.6, 7.8 and 3.9µg/ml) were incubated in
50 µl Luria Bertani broth containing 50 µl of 106
CFU/ml of reference strains of S. aureus (ATCC
25923) E. coli (ATCC 25922) and C. albicans for
18 hours at 37°C. After an overnight incubation, the
plate was analysed by reading the absorbance at
620 nm using the ELISA plate reader (Zynth). The
MIC of peptide samples were recorded as the lowest
concentration where no viability was observed in
the wells of 96 microtiter plate after 18 hours.
Haemolytic effect of the antimicrobials frogs’
peptides was investigated using human red blood
cells (RBC). The RBC were centrifuged at 1800 rcf
for 10 min and resuspended in phosphate buffer
saline (PBS) to give 5x107 cells count. Skin
secretions were prepared in the concentrations of
100, 50, 25, 12.5, 6.25, 3.125 and 1.56 µg/ml and
incubated with the RBC at 37°C for 1 hour. RBC
were centrifuged at 12000 g for 30 sec and the
absorbance of supernatant was measured at 450 nm.
Total lysis of erythrocyte suspension was obtained
by incubating the cells with 1 % v/v Tween 20.
Ampicilin was used as the positive control against
E. coli and S. aureus while Amphotericin-B was
used as the positive control against C. albicans.
The observed bands from all samples are found
concentrated towards the bottom of the gel
corresponding to the peptides of lower molecular
mass (1-3.5 kDa) (Figure 1). This observation is
agreeable to the published reports on similar studies
where most AMPs have low molecular mass ranging
from 1 to 5 kDa (Conlon 2007, Conlon et al., 2008;
Conlon & Mechkarska, 2014; He et al., 2013;
Memarpoor-Yazdi et al., 2013). Among the peptides
isolated from the Bornean frogs are Brevinin-2LSa
(2815.5Da), Esculentin-1LSa (4637.6Da), Palustrin-
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Fig. 1. Silver stained Tricine SDS-Page gel of partially purified secretions from Bornean Ranidae.  (A) Lane M represents
protein marker (Sigma Aldrich) ranging from 26.6 to 1.0 kDa. Lane 1: C. raniceps, lane 2: P. signata, lane 3: P. glandulosa
and lane 4: P. baramica. (B) Lane M represents marker, lane 5:  O. hosii, lane 6:  M. jerboa.
2LSa (3020.5Da), Temporin-LSa (1361.8Da),
Brevinin-2SGa (3126.7Da) and Temporin-SGa
(1673Da) (Conlon and Mechkarska; 2014). Further
purification steps will largely resolve the molecular
weights of the corresponding peptides from the
studied Bornean frogs.
Disc diffusion assay (Table 1) indicates the
presence of antimicrobial activities of the partially
purified peptides against E. coli, S. aureus and C.
albicans (Figure 2, 3 and 4). Based on the diameter
of the inhibition zones formed, the highest activity
was shown by the peptides (500 µg/ml) from M.
jerboa and P. signata with 14.33 mm and 13.67 mm,
respectively, against the gram negative E. coli.
Peptides from P. baramica, C. raniceps, P.
glandulosa and O. hosii demonstrated relatively
comparable potency against E. coli with the formed
inhibition zone diameters between 7-9 mm. Peptides
from P. baramica and O. hosii (500 µg/ml) had
higher antimicrobial effect on the gram positive
S. aureus with the inhibition zones diameter of
approximately 14.67 mm and 14.00 mm,
respectively. As for the antimicrobial effect against
C. albicans, most of the tested peptides showed
comparable potency against the fungi with the
highest diameter exhibited by the peptides from
P. baramica, while P. glandulosa did not exhibit
any inhibition effect on C. albicans at 500 µg/ml.
Determinations of the minimum inhibitory concen-
trations (MIC) of the frogs’ peptides further elucidate
the antimicrobial characteristics of these peptides.
Figures 2 to 4 show increased antimicrobial
potency against E. coli, S. aureus and C. albicans
with increasing concentrations of the partially
purified peptides from the frogs’ skin. P. glandulosa
and P. baramica showed the highest antimicrobial
activities against E. coli with the MIC of 31.3
µg/ml. The MIC of P. glandulosa, P. signata, C.
raniceps and P. baramica against S. aureus were
found to be more than 500, 250 and 125 µg/ml,
respectively (Table 1). P. baramica showed the
highest antimicrobial activity against S. aureus as
compared to other tested species with the MIC of
125 µg/ml. Previous structure-activity relationship
studies suggested that the antimicrobial activity of
AMPs is significantly dependent on their α-helical
structure, which is affected by charge, size, helicity
and hydrophobicity (Jiang et al., 2008; Tossi et al.,
2000). Thus, further investigations on the secondary
structures of the purified peptides will enhance the
knowledge and information regarding the Bornean
frogs’ AMPs.
The toxicity assay shows low haemolytic
activity (less than 50% cell lysis) at the con-
centration below 12.5 µg/ml for all skin peptides
(Figure 5). However, at the AMPs concentration
of 100 µg/ml, partially purified peptides from C.
raniceps, P. baramica and P. glandulosa caused
more than 50% blood cell lysis. Interestingly,
only P. signata peptides demonstrated less toxicity
against the red blood cells in which at 100 µg/ml,
the partially purified secretions caused appro-
ximately 23% cell lysis. It is generally accepted that
AMP isolated from frog secretions have the
characteristics of being toxic to mammalian cells
(Jiang et al., 2014). The mechanism of which the
RBC lyses upon reacting with AMP was not being
studied in this project. However, the current findings
strongly supported that the extreme toxicity of AMP
is related to its higher hydrophobicity (Conlon et
al., 2008).
To conclude, this study shows that the skin
peptides from P. baramica, C. raniceps, P. signata
P. glandulosa, O. hosii and M. jerboa exhibit
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Table 1.  Inhibition zone of post Sep-Pak peptide secretions after incubation with E. coli, S.
aureus and C. albicans. 20 µl of peptide samples were incubated at 37°C with E. coli, S. aureus
and C. albicans.  After 24 hours, the clear zone surrounding disk impregnated with peptide
samples were measured using a ruler.  Values were displayed as mean ± SD of triplicates
from a single experiment, representative of three separate experiments.
Fig. 2. Minimum inhibitory concentrations of peptides from Bornean Ranidae against the growth of E. coli.
Partially purified peptides of P. baramica, P. signata, P. glandulosa, O. hosii, M. jerboa and C. raniceps at
concentrations ranging from 500 µg/ml to 3.9 µg/ml were incubated with E. coli at 1 × 106 CFU/ml. After 24
hours, the bacterial growth were analysed by reading the optical density at 620 nm using ELISA plate reader.
Values were displayed as mean ± SD of triplicates from a single experiment, representative of three separate
experiments.
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Fig. 3. Minimum inhibitory concentrations of peptides from Bornean Ranidae against the growth of S.aureus.
Partially purified peptides of P. baramica, P. signata, P. glandulosa, O. hosii, M. jerboa and C. raniceps at
concentrations ranging from 500 µg/ml to 3.9 µg/ml were incubated with S. aureus at 1 × 106 CFU/ml. After
24 hours, the bacterial growth were analysed by reading the optical density at 620 nm using ELISA plate
reader. Values were displayed as mean ± SD of triplicates from a single experiment, representative of three
separate experiments.
Fig. 4. Minimum inhibitory concentrations of peptides from Bornean Ranidae against the growth of C.
albicans. Partially purified peptides of P. baramica, P. signata, P. glandulosa, O. hosii, M. jerboa and C.
raniceps at concentrations ranging from 500 µg/ml to 3.9 µg/ml were incubated with C. albicans at 1 × 106
CFU/ml. After 24 hours, the fungal growth were analysed by taking the optical density at 620 nm using
ELISA plate reader. Values were displayed as mean ± SD of triplicates from a single experiment,
representative of three separate experiments.
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Table 2. Minimum Inhibitory Concentrations of Bornean
Ranidae peptides against bacterial growth. Partially purified
peptides of P. baramica, P. signata, P. glandulosa, O. hosii,
M. jerboa and C. raniceps at concentrations ranging from
500µg/ml to 3.9 µg/ml were incubated with E. coli, S.
aureus and C. albicans  at  1 × 106 CFU/ml. After 24 hours,
the bacterial growth were analysed by taking the optical
density at 620 nm using ELISA plate reader. Results are
displayed as representative of three separate experiments
Minimum inhibitory concentrations
(µg/ml)
E. coli S. aureus C. albicans
P. glandulosa 31.3 >500 >500
P. signata 250 250 250
P. baramica 31.3 125 250
C. raniceps 62.5 250 250
O. hosii 250 250 125
M. jerboa 125 250 125
Fig. 5. Hemolytic activity of frog skin secretions on human erythrocytes. Skin secretions after Sep-Pak purification were
incubated with 5 × 107 RBC at 37°C in the concentration ranges from 1.56 to 100 µg/ml. After 1 hour, the RBC lysis were
analysed using ELISA plate reader. Results are displayed as mean ± SD of triplicates from a single experiment representative
of three separate experiments.
apparent antimicrobial activity against gram
positive and gram negative bacteria as well as being
associated with relatively strong haemolytic activity.
The current preliminary data can fill the gap on the
knowledge of frogs AMPs and gives deeper insight
on the potential of the skin peptides of Bornean
frogs against nosocomial bacterial pathogens.
Further works need to be conducted to isolate and
purify these peptides to homogeneity and sub-
sequently perform the structural characterization
of the purified peptides. The potency of these skin
peptides against microorganisms makes them the
attractive candidates for the development into
therapeutically anti-infective agents. However, due
to the adverse haemolytic effects of the peptides on
the red blood cells, certain chemical modifications
should be done prior to further development of
these host defense peptides.
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